Presentation TCT 2015 The Role (and Timing) of Complete Revascularization in AMI and Cardiogenic Shock Presenter: Holger Thiele October 14, 2015 REGISTER for free or LOG IN to view this content Presentation TCT 2015 Up Next Presentation TCT 2015 New Randomized Trial Data (2-Year Outcomes): ABSORB II (TCT First Report Investigation Results and Beyond) Presenter: Bernard R. Chevalier October 14, 2015 More slides + Presentation TCT 2015 The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status Presenter: Roxana Mehran October 14, 2015 Presentation TCT 2015 CE-Approved or EU Studies: JenaValve Technology Review and Clinical Update (JUPITER Trials) Presenter: Hendrik Treede October 14, 2015 We Recommend
Presentation TCT 2015 New Randomized Trial Data (2-Year Outcomes): ABSORB II (TCT First Report Investigation Results and Beyond) Presenter: Bernard R. Chevalier October 14, 2015
Presentation TCT 2015 The PIONEER Trial (Rivaroxaban in Patients With ACS and Atrial Fibrillation): Design, Rationale, and Status Presenter: Roxana Mehran October 14, 2015
Presentation TCT 2015 CE-Approved or EU Studies: JenaValve Technology Review and Clinical Update (JUPITER Trials) Presenter: Hendrik Treede October 14, 2015